MetLife (MET) Q2 2025: Asia Sales Jump 29% in Japan, Offsetting Underwriting Drag
MetLife’s Q2 2025 results reveal a business balancing near-term underwriting volatility with resilient top-line growth and disciplined expense management. Asia and Latin America delivered standout volume gains, while strategic capital deployment and new platforms like Chariot Re reinforce the insurer’s push into asset management and risk transfer. Management signals confidence in earnings normalization and continued capital returns as new initiatives scale in the second half.
Summary
- Asia Product Launches Drive Growth: New FX and annuity offerings in Japan and Korea accelerated sales momentum.
- Expense Discipline Cushions Margin: Direct expense ratio beat targets despite variable investment income headwinds.
- Strategic Platforms Expand Reach: Chariot Re and Pinebridge acquisitions position MetLife at the insurance-asset management intersection.
Performance Analysis
MetLife’s Q2 earnings reflect a portfolio navigating both cyclical and idiosyncratic headwinds, with adjusted earnings of $1.4 billion down year-over-year, primarily due to less favorable underwriting and lower variable investment income (VII). Group Benefits, which comprises a significant share of MetLife’s U.S. franchise, saw earnings contract 25% from a record prior year, driven by elevated claims across life and non-medical health products. However, adjusted premiums, fees, and other revenues (PFOs) in Group Benefits grew 4%, with year-to-date sales up 9%, underscoring resilient demand in core and voluntary lines.
Asia, now accounting for over 40% of MetLife’s VII assets, posted a 22% drop in adjusted earnings, largely on VII and underwriting margin pressure, but sales in Japan and Korea surged 29% and 36% respectively on new product launches. Latin America and EMEA delivered robust volume-driven growth, with Latin America’s adjusted earnings up 15% on a constant currency basis, and EMEA’s up 30%. Expense management remained a bright spot, as the direct expense ratio of 11.7% beat the annual target, supporting margin even as investment returns lagged. Free cash flow enabled $900 million in capital returns, including $500 million in buybacks.
- Underwriting Fluctuations Impact Group Benefits: Elevated claims in select non-medical health products and a few large disability cases drove margin pressure.
- Asia Sales Outperform Despite Earnings Dip: New FX and annuity products in Japan and Korea drove double-digit sales growth, offsetting VII drag.
- Latin America and EMEA Sustain Volume Growth: Diversified distribution and embedded insurance platforms fueled outperformance.
Despite short-term margin and investment pressures, MetLife’s diversified business lines and disciplined cost control provide ballast, with management guiding to sequential improvement in underwriting and continued capital deployment in the second half.
Executive Commentary
"We demonstrated all-weather performance and clear momentum across business segments, posting strong sales in many markets, executing strategic transactions, maintaining a laser focus on managing expenses, and returning capital to shareholders... Although the second quarter does not demonstrate the full earnings power of MetLife, we're confident in our ability to deliver on the commitments of our new frontier strategy."
Michelle Halaf, President and Chief Executive Officer
"While our earnings power was not fully evident this quarter given the lower than expected variable investment income, we remain confident in delivering all weather performance achieved through a position of strength with a strong balance sheet and recurring free cash flow generation."
John McCallion, Chief Financial Officer and Head of MetLife Investment Management
Strategic Positioning
1. Asia Product Innovation and Distribution Scale
MetLife’s Asia segment is leveraging product innovation and cross-market expertise to drive outsized sales growth. The launch of single premium FX and annuity products in Japan and Korea, supported by robust distribution channels, enabled sales to rise 29% and 36% respectively. Persistency rates are stabilizing, and higher local interest rates are improving economics for yen-denominated offerings, while FX products remain attractive due to rate differentials.
2. Asset Management and Risk Transfer Expansion
The acquisition of Pinebridge Investments and the launch of Chariot Re signal a pivot toward integrating insurance and asset management capabilities. Chariot Re, with an initial $10 billion reinsurance deal, is designed to support MetLife’s retirement platform and generate institutional AUM, with future transactions focused on MetLife-originated liabilities. These moves are intended to diversify earnings and reduce enterprise risk, particularly as capital markets evolve.
3. Group Benefits Resilience and Digital Enablement
Despite underwriting volatility, Group Benefits is capitalizing on digital tools and partnerships to drive participation and efficiency. The Upwise benefits experience platform, now partnered with Workday, is improving voluntary product take-up and streamlining employer-employee engagement. Regional business growth is offsetting a slower jumbo year, with competitive differentiation anchored in broker relationships and service capabilities.
4. Latin America Embedded Insurance Growth
LATAM’s performance is underpinned by digital ecosystem partnerships and embedded insurance solutions. The Accelerator platform has rapidly scaled, issuing $300 million in PFOs and serving 5 million customers through over 100 third-party partners, supporting double-digit top-line growth and reinforcing MetLife’s regional leadership.
5. Expense and Capital Management Discipline
MetLife’s focus on maintaining a low expense ratio and ample liquidity buffer underpins its ability to invest and return capital. The company ended the quarter with $5.2 billion in holding company liquidity, above its target range, and has pre-funded upcoming redemptions and maturities. Consistent share repurchases have reduced the share count by over 240 million since 2021, even as growth investments continue.
Key Considerations
This quarter’s results highlight how MetLife’s diversified model, spanning insurance, reinsurance, and asset management, provides both resilience and optionality. While underwriting and investment income can be volatile, the company’s ability to grow sales across geographies and product lines, invest in technology, and deploy capital strategically is central to its long-term thesis.
Key Considerations:
- Asia Sales Momentum: Product innovation and channel leverage are driving sustained growth, with upside from improved persistency and local rate tailwinds.
- Group Benefits Normalization: Management expects underwriting ratios to improve sequentially, with dental and disability trends in line with historical patterns.
- Strategic Transactions and Capital Allocation: Pinebridge and Chariot Re are positioned to diversify revenue and reduce risk, while capital returns remain robust.
- Expense Efficiency as Competitive Advantage: Sub-12% expense ratio provides margin support and flexibility to invest in growth and technology.
- Latin America’s Embedded Insurance Scale: Digital partnerships are accelerating customer acquisition and premium growth, reinforcing regional leadership.
Risks
MetLife faces ongoing risks from underwriting volatility, especially in non-medical health and disability lines, as well as continued uncertainty around variable investment income, which is inherently difficult to forecast. Exposure to commercial mortgage loans and global macroeconomic shifts, particularly in Asia, could impact earnings variability and capital ratios. Strategic initiatives such as Chariot Re and Pinebridge integration must execute as planned to deliver intended diversification and risk mitigation.
Forward Outlook
For Q3 2025, MetLife guided to:
- Sequential improvement in Group Benefits underwriting ratios, with a 200 basis point improvement expected in non-medical health.
- Stable core spreads in Retirement and Income Solutions, with some seasonality in Q3 and normalization in Q4.
For full-year 2025, management maintained guidance:
- Adjusted ROE near mid-teen targets, with expense discipline and capital return priorities unchanged.
Management highlighted several factors that will drive results:
- Normalization of underwriting experience in Group Benefits and Asia.
- Continued sales momentum in Asia, Latin America, and EMEA.
Takeaways
MetLife’s Q2 results reinforce the importance of its diversified business mix and disciplined execution, with strategic investments in asset management and digital platforms setting up for improved earnings power as underwriting and investment income normalize.
- Asia and Latin America are driving top-line resilience, with new products and digital distribution offsetting cyclical headwinds in U.S. underwriting.
- Strategic platforms like Chariot Re and Pinebridge are intended to reshape MetLife’s earnings profile, but will require continued execution and integration to deliver on diversification promises.
- Investors should watch for normalization in underwriting margins, further capital deployment, and the scaling of new platforms as key drivers of valuation and risk in the coming quarters.
Conclusion
MetLife’s Q2 2025 results reflect a business in transition, with near-term underwriting and investment headwinds balanced by strong sales, disciplined expenses, and strategic moves into asset management and reinsurance. The company’s ability to deliver on margin normalization and scale new initiatives will determine its path to sustained outperformance.
Industry Read-Through
MetLife’s performance offers several signals for the broader life insurance and asset management sectors. The resilience of sales in Asia and Latin America underscores the importance of geographic and product diversification, while underwriting volatility in health and disability lines is a sector-wide theme. The integration of asset management and insurance platforms, as seen with Pinebridge and Chariot Re, reflects an industry shift toward capital-light, fee-based revenue streams and risk transfer solutions. Competitors will need to accelerate digital enablement, embedded insurance, and capital discipline to match evolving customer and investor expectations.